AstraZeneca 4Q Revenues: $14.9 billion (+24%) 4Q Earnings: $1.5 billion (+56%) FY Revenues: $54.1 billion (+18%) FY Earnings: $7.0 billion (+18%) Comments: Oncology sales were $22.4 billion, up 21%.
Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...
Andelyn Biosciences, Inc., a cell and gene therapy CDMO, has expanded its AAV Curator Platform offering and License Agreement with the Broad Institute of MIT and Harvard to include the Stanton Lab CNS ...
Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback